Cargando…
Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance
Hairy cell leukemia (HCL) is a rare type of chronic lymphoid leukemia originating from a mature B lymphocyte. A diagnosis of HCL is based on cytology, confirmed by multiparametric flow cytometry (MFC) studies using anti-B-cell monoclonal antibodies, together with a panel of antibodies more specific...
Autores principales: | Robak, Tadeusz, Robak, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684202/ https://www.ncbi.nlm.nih.gov/pubmed/36439497 http://dx.doi.org/10.3389/fonc.2022.976374 |
Ejemplares similares
-
Skin changes in hairy cell leukemia
por: Robak, Ewa, et al.
Publicado: (2020) -
Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
por: Robak, Tadeusz, et al.
Publicado: (2021) -
The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications
por: Puła, Anna, et al.
Publicado: (2021) -
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
por: Ravandi, Farhad, et al.
Publicado: (2022) -
Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
por: Robak, Ewa, et al.
Publicado: (2023)